The Antisera market in Canada shows a steady upward trend from 2024 to 2028 with a per capita value starting at $303.37 USD in 2024 and rising to $321.69 USD in 2028. Comparing to 2023, where the per capita value stood at $298.00 USD, the forecasted data reflects a consistent year-on-year growth of around 1.6% to 1.8%. Between 2023 and 2028, the Compound Annual Growth Rate (CAGR) is estimated at approximately 1.9%, indicating a modest but stable market growth over the five-year period.
Future trends to watch include potential advancements in antisera production technologies that could reduce costs and accelerate market expansion. Additionally, government healthcare policies and funding for immunotherapies might influence future market dynamics significantly.
